Valneva SE (VALN) stock
VALNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$5.34−0.23 (-4.04%)
Close on Nov 18, 2026Market cap $463.35MP/E –Yield –
Valneva cash
Cash and short-term investments held at the end of each period.
Valneva's cash was €121.53M at Jun 30, 2026. For fiscal 2025 it was €109.65M, down 34.8% from the year before. The highest annual figure on record is €346.69M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | €109.65M | -34.8% |
| FY2024 | Dec 31, 2024 | €168.27M | +33.5% |
| FY2023 | Dec 31, 2023 | €126.08M | -56.0% |
| FY2022 | Dec 31, 2022 | €286.53M | -17.4% |
| FY2021 | Dec 31, 2021 | €346.69M | +69.6% |
| FY2020 | Dec 31, 2020 | €204.44M | +217.3% |
| FY2019 | Dec 31, 2019 | €64.44M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | €121.53M | -24.7% |
| Q1 FY2026 | Mar 31, 2026 | €105.27M | -31.2% |
| Q4 FY2025 | Dec 31, 2025 | €109.65M | -34.8% |
| Q3 FY2025 | Sep 30, 2025 | €143.46M | -8.2% |
| Q2 FY2025 | Jun 30, 2025 | €161.31M | +22.7% |
| Q1 FY2025 | Mar 31, 2025 | €152.99M | -13.4% |
| Q4 FY2024 | Dec 31, 2024 | €168.27M | +33.5% |
| Q3 FY2024 | Sep 30, 2024 | €156.34M | -8.7% |
| Q2 FY2024 | Jun 30, 2024 | €131.41M | -35.7% |
| Q1 FY2024 | Mar 31, 2024 | €176.64M | -30.6% |
| Q4 FY2023 | Dec 31, 2023 | €126.08M | -56.0% |
| Q3 FY2023 | Sep 30, 2023 | €171.25M | -34.4% |
| Q2 FY2023 | Jun 30, 2023 | €204.41M | -39.2% |
| Q1 FY2023 | Mar 31, 2023 | €254.49M | -18.2% |
| Q4 FY2022 | Dec 31, 2022 | €286.53M | -17.4% |
| Q3 FY2022 | Sep 30, 2022 | €261.04M | +5.3% |
| Q2 FY2022 | Jun 30, 2022 | €336.23M | +2.0% |
| Q1 FY2022 | Mar 31, 2022 | €311.26M | +31.9% |
| Q4 FY2021 | Dec 31, 2021 | €346.69M | +69.6% |
| Q3 FY2021 | Sep 30, 2021 | €247.95M | +284.8% |
| Q2 FY2021 | Jun 30, 2021 | €329.77M | – |
| Q1 FY2021 | Mar 31, 2021 | €235.91M | – |
| Q4 FY2020 | Dec 31, 2020 | €204.44M | – |
| Q4 FY2019 | Dec 31, 2019 | €64.44M | – |
See a number that looks wrong?